These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 9499187)
1. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Jacquet P; Averbach A; Stephens AD; Stuart OA; Chang D; Sugarbaker PH Oncology; 1998; 55(2):130-8. PubMed ID: 9499187 [TBL] [Abstract][Full Text] [Related]
2. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. Sugarbaker PH; Stuart OA; Carmignani CP Cancer Chemother Pharmacol; 2006 May; 57(5):703-8. PubMed ID: 16096789 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intraperitoneal mitomycin C. van Ruth S; Verwaal VJ; Zoetmulder FA Surg Oncol Clin N Am; 2003 Jul; 12(3):771-80. PubMed ID: 14567030 [TBL] [Abstract][Full Text] [Related]
5. Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy. Kemmel V; Mercoli HA; Meyer N; Brumaru D; Romain B; Lessinger JM; Brigand C Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S873-9. PubMed ID: 26100819 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusion. Cerretani D; Nencini C; Urso R; Giorgi G; Marrelli D; De Stefano A; Pinto E; Cioppa T; Nastri G; Roviello F J Chemother; 2005 Dec; 17(6):668-73. PubMed ID: 16433199 [TBL] [Abstract][Full Text] [Related]
7. Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis. Sørensen O; Andersen AM; Kristian A; Giercksky KE; Flatmark K J Surg Oncol; 2014 May; 109(6):521-6. PubMed ID: 24347444 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan. Sugarbaker PH; Stuart OA Cancer Chemother Pharmacol; 2007 Feb; 59(2):151-5. PubMed ID: 17091250 [TBL] [Abstract][Full Text] [Related]
9. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Glehen O; Stuart OA; Mohamed F; Sugarbaker PH Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586 [TBL] [Abstract][Full Text] [Related]
10. Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. Fernández-Trigo V; Stuart OA; Stephens AD; Hoover LD; Sugarbaker PH Cancer Treat Res; 1996; 81():51-61. PubMed ID: 8834575 [TBL] [Abstract][Full Text] [Related]
11. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714 [TBL] [Abstract][Full Text] [Related]
12. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study. Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411 [TBL] [Abstract][Full Text] [Related]
13. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Witkamp AJ; de Bree E; Kaag MM; Boot H; Beijnen JH; van Slooten GW; van Coevorden F; Zoetmulder FA Eur J Cancer; 2001 May; 37(8):979-84. PubMed ID: 11334722 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. van Ruth S; Mathôt RA; Sparidans RW; Beijnen JH; Verwaal VJ; Zoetmulder FA Clin Pharmacokinet; 2004; 43(2):131-43. PubMed ID: 14748621 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy. Kuzuya T; Yamauchi M; Ito A; Hasegawa M; Hasegawa T; Nabeshima T J Pharm Pharmacol; 1994 Aug; 46(8):685-9. PubMed ID: 7815285 [TBL] [Abstract][Full Text] [Related]
16. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Kusamura S; Baratti D; Younan R; Laterza B; Oliva GD; Costanzo P; Favaro M; Gavazzi C; Grosso F; Deraco M Ann Surg Oncol; 2007 Sep; 14(9):2550-8. PubMed ID: 17558537 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration. Sugarbaker PH; Stuart OA; Vidal-Jove J; Pessagno AM; DeBruijn EA Cancer Treat Res; 1996; 82():41-52. PubMed ID: 8849942 [TBL] [Abstract][Full Text] [Related]
18. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C. Lange KN; McKay D; Gentry BG; Franko J Ann Surg Oncol; 2017 Dec; 24(13):3837-3841. PubMed ID: 29019106 [TBL] [Abstract][Full Text] [Related]
20. Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Weber T; Roitman M; Link KH Clin Colorectal Cancer; 2012 Sep; 11(3):167-76. PubMed ID: 22397952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]